Smith & Nephew Plc SNN 深 滬
已收盤 08-01 16:00:00 美东时间
30.83
+0.270
+0.88%
華盛通- 最 高30.92
- 今 開30.58
- 成交量 95.11万股
- 最 低 30.33
- 昨 收 30.56
- 總市值 135.04亿
- 52周最高 31.84
- 市盈率 靜 32.76
- 換手率 0.22%
- 52周最低 23.243
- 委 比 40.56%
- 總股本 4.38亿
- 歷史最高 48.168
- 量 比 1.60
- 振 幅 1.93%
- 歷史最低 8.968
- 每 手 1
- 風險率 2.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Smith+Nephew to Announce Q2 and H1 2025 Results on August 5
The latest announcement is out from Smith & Nephew Snats ( ($SNN) ). Smith+...
07-21 21:16
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
Smith+Nephew launched the Q-FIX KNOTLESS All-Suture Anchor, a medical device for soft tissue-to-bone fixation in shoulder, hip, and foot & ankle repairs. The product offers market-leading strength, consistent deployment, superior tissue security, and streamlined suture handling. It features MINITAPE or ULTRABRAID sutures, providing enhanced performance and reducing displacement during cyclic loading. Surgeons like Dr. Robert Litchfield praise its...
07-07 14:00
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
Smith+Nephew announces continued support for select Wimbledon players in 2025, aligning with its "Life Unlimited" mission to enhance patient care through innovative Sports Medicine solutions. The company highlights its advanced technologies, including the REGENETEN Bioinductive Implant, CARTIHEAL AGILI-C Cartilage Repair Implant, and Q-FIX KNOTLESS All-Suture Anchor, which address injuries common in high-impact sports like tennis. These products ...
06-29 11:00
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
<p>Smith+Nephew has launched the TRIGEN MAX Tibia Nailing System for treating stable and unstable tibia fractures. The system features side-specific nails, variable angle locking technology, and components like a modular drop system, 12.5mm channel reamer, and 5.0mm lag screws to streamline surgeries and enhance fixation. Designed with a patient-centered approach, it optimizes recovery and adapts to individual anatomy. The system is currently ava...
06-24 14:00
Smith+Nephew Backs UK's First Orthopaedic Surgery Center to Cut NHS Wait Times and Speed Up Joint Care
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic
06-18 16:12
Smith+Nephew Appoints New Non-Executive Director
Smith & Nephew Snats ( ($SNN) ) just unveiled an announcement. Smith+Nephew...
06-13 23:27
Smith+Nephew Introduces New Medial Stabilized Insert For LEGION Total Knee System
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a
06-09 22:04
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
Smith+Nephew introduced a new medial stabilized insert for its LEGION Total Knee System, leveraging growing popularity of this design in knee replacement procedures. Designed for both PCL-retaining and PCL-substituting surgeries, it offers a bone-conserving approach and streamlined procedures. The insert features a larger anterior medial lip and natural knee kinematics, aligned with current clinical trends. With over 20 years of clinical success,...
06-09 14:00
Smith & Nephew Announces Managerial Stock Transactions
Smith & Nephew Snats ( ($SNN) ) has provided an announcement. On June 6, 20...
06-07 01:47
Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Sionna Therapeutics, a clinical-stage biopharmaceutical company focused on revolutionizing cystic fibrosis (CF) treatment by developing medicines that normalize CFTR protein function, announced that its management will participate in a fireside chat at the Goldman Sachs 46th Annual Healthcare Conference on June 11, 2025. A live webcast and replay of the presentation will be available on the company’s Investors website.
06-03 11:00
